Literature DB >> 22571706

Investigations of selected historically important syndromic outbreaks: impact and lessons learned for public health preparedness and response.

Richard A Goodman1, Joseph M Posid, Tanja Popovic.   

Abstract

Public health readiness has increased at all jurisdictional levels because of increased sensitivity to threats. Since 2001, with billions of dollars invested to bolster the public health system's capacity, the public expects that public health will identify the etiology of and respond to events more rapidly. However, when etiologies are unknown at the onset of the investigation but interventions must be implemented, public health practitioners must benefit from past investigations' lessons to strengthen preparedness for emerging threats. We have identified such potentially actionable lessons learned from historically important public health events that occurred primarily as syndromes for which the etiological agent initially was unknown. Ongoing analysis of investigations can advance our capability to recognize and investigate syndromes and other problems and implement the most appropriate interventions.

Mesh:

Year:  2012        PMID: 22571706      PMCID: PMC3483947          DOI: 10.2105/AJPH.2011.300426

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  73 in total

1.  Outbreak of severe acute respiratory syndrome--worldwide, 2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2003-03-21       Impact factor: 17.586

2.  Syndromic surveillance for bioterrorism following the attacks on the World Trade Center--New York City, 2001.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-09-11       Impact factor: 17.586

3.  Epidemiology of diarrheal disease outbreaks on cruise ships, 1986 through 1993.

Authors:  D Koo; K Maloney; R Tauxe
Journal:  JAMA       Date:  1996-02-21       Impact factor: 56.272

4.  Acquired immune deficiency syndrome (AIDS): precautions for clinical and laboratory staffs.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1982-11-05       Impact factor: 17.586

5.  [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children].

Authors:  T Kawasaki
Journal:  Arerugi       Date:  1967-03

6.  SARS: mobilizing and maintaining a public health emergency response.

Authors:  Joseph M Posid; Sherrie M Bruce; Julie T Guarnizo; Melissa L Taylor; Brenda W Garza
Journal:  J Public Health Manag Pract       Date:  2005 May-Jun

7.  Toxic epidemic syndrome, Spain, 1981. Toxic Epidemic Syndrome Study Group.

Authors: 
Journal:  Lancet       Date:  1982-09-25       Impact factor: 79.321

8.  An outbreak of a newly recognized chronic diarrhea syndrome associated with raw milk consumption.

Authors:  M T Osterholm; K L MacDonald; K E White; J G Wells; J S Spika; M E Potter; J C Forfang; R M Sorenson; P T Milloy; P A Blake
Journal:  JAMA       Date:  1986-07-25       Impact factor: 56.272

9.  West Nile virus activity--United States, August 7-13, 2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2003-08-15       Impact factor: 17.586

10.  Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977.

Authors:  L B Schonberger; D J Bregman; J Z Sullivan-Bolyai; R A Keenlyside; D W Ziegler; H F Retailliau; D L Eddins; J A Bryan
Journal:  Am J Epidemiol       Date:  1979-08       Impact factor: 4.897

View more
  2 in total

1.  Shiga Toxin-Producing Escherichia coli (STEC) O157:H7 and Romaine Lettuce: Source Labeling, Prevention, and Business.

Authors:  Gregory M Astill; Fred Kuchler; Jessica E Todd; Elina T Page
Journal:  Am J Public Health       Date:  2020-01-16       Impact factor: 9.308

2.  Missouri K-12 school collection and reporting of school-based syndromic surveillance data: a cross sectional study.

Authors:  Terri Rebmann; Allison K Kunerth; Alan Zelicoff; Michael B Elliott; Harper F Wieldt
Journal:  BMC Public Health       Date:  2016-02-01       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.